Evidence-based guidelines for the pharmacological treatment of migraine

Other authors

Institut Català de la Salut

[Ornello R] Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy. [Caponnetto V] Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy. [Ahmed F] Hull University Teaching Hospitals NHS Trust, Hull, UK. [Al-Khazali HM] Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. [Ambrosini A] Headache Clinic - IRCCS NEUROMED, Pozzilli, Italy. [Ashina S] Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA. Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. [Pozo-Rosich P] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-06-13T10:17:01Z

2025-06-13T10:17:01Z

2025-04



Abstract

Acute treatment; Migraine treatment; Preventive treatment


Tractament agut; Tractament de la migranya; Tractament preventiu


Tratamiento agudo; Tratamiento de la migraña; Tratamiento preventivo


We here present evidence-based guidelines for the pharmacological treatment of migraine. These guidelines, created by the Italian Society for the Study of Headache and the International Headache Society, aim to offer clear, actionable recommendations to healthcare professionals. They incorporate evidence-based recommendations from randomized controlled trials and expert-based opinions. The guidelines follow the Grading of Recommendations, Assessment, Development and Evaluation approach for assessing the quality of evidence. The guideline development involved a systematic review of literature across multiple databases, adherence to Cochrane review methods, and a structured framework for data extraction and interpretation. Although the guidelines provide a robust foundation for migraine treatment, they also highlight gaps in current research, such as the paucity of head-to-head drug comparisons and the need for long-term outcome studies. These guidelines serve as a resource to standardize migraine treatment and promote high-quality care across different healthcare settings.

Document Type

Article


Published version

Language

English

Publisher

SAGE Publications

Related items

Cephalalgia;45(4)

https://doi.org/10.1177/03331024241305381

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)